EPHA2, EPH receptor A2, 1969

N. diseases: 187; N. variants: 10
Disease: Malignant neoplasm of prostate ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate 		0.030 Biomarker disease BEFREE This study investigated whether EPHA2 is useful in predicting the biochemical recurrence of prostate cancer. 31704854 2019
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate 		0.030 Biomarker disease BEFREE YSA is an EphA2-targeting peptide that effectively delivers anticancer agents to prostate cancer tumors. 23155185 2013
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate 		0.030 AlteredExpression disease BEFREE Clinically, expression of Vav3 and EphA2 was elevated in late-stage and metastatic prostate cancers. 22659453 2012